LBC | CER+ve (%) | HR HC2+ve (%) | κ (95% CI) |
---|---|---|---|
Normal (Pap I/II) | 10.8% | 5.7% | 0.53 (0.43-0.61) |
ASC-US (Pap IIw) | 30.8% | 27.7% | 0.55 (0.33-0.78) |
ASC-H, AGUS (Pap III) | 50.0% | 45.0% | 0.9 (0.71-1.0) |
LSIL, HSIL (Pap IIID) | 67.2% | 71.5% | 0.82 (0.75-0.88) |
HSIL, CIS (Pap IVa) | 97.2% | 100 % | 1 |
HSIL, CIS, Micro (IVb) | 100% | 100% | 1 |
Microinvasive (Pap V) | 100% | 100% | 1 |
AGUS+ (≥Pap III) | 71.3% | 75.2% | 0.83 (0.77-0.88) |
HSIL+ (≥Pap IVa) | 100% | 100% | 1 |
Total | 27.8% | 25.2% | 0.8 (0.77-0.84) |